Telehealth Diet Management for Stomach Cancer Post-Surgery
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinator or your doctor.
What data supports the effectiveness of the treatment Diet Support Intervention, Telemedicine Visit, Temodar, Temodal, TMZ, SCH 52365, NSC 362856 for stomach cancer post-surgery?
Research shows that personalized nutritional and educational interventions can improve nutritional status and treatment compliance in gastric cancer patients undergoing chemotherapy. Additionally, post-discharge nutritional supplements with dietary advice have been shown to improve nutritional outcomes and quality of life in patients at nutritional risk after surgery for gastric cancer.12345
Is telehealth diet management safe for stomach cancer post-surgery?
The studies reviewed focus on the effectiveness of nutritional interventions after stomach cancer surgery, but they do not provide specific safety data for telehealth diet management. However, these interventions generally aim to improve nutrition and quality of life, suggesting they are designed with patient safety in mind.12567
How is the Telehealth Diet Management treatment for stomach cancer post-surgery different from other treatments?
This treatment is unique because it uses telehealth (remote healthcare services) to provide personalized diet management for stomach cancer patients after surgery, focusing on early and intensive nutrition care to improve quality of life and weight preservation. It leverages digital tools like mobile applications and wearable devices to deliver tailored interventions, which is a novel approach compared to traditional in-person dietetic services.128910
What is the purpose of this trial?
This clinical trial test whether taking part in a diet support intervention will help with patients nutrition and quality of life after surgery for esophagus or stomach cancer. The information learned by doing this research study may help patients get more information and/or support on eating after esophagus and stomach cancer surgery.
Research Team
Jae Y Kim
Principal Investigator
City of Hope Medical Center
Eligibility Criteria
This trial is for adults over 21 who've had surgery to remove stomach or gastroesophageal junction cancer and are starting to eat orally again. Participants must understand English or Spanish, be able to give informed consent, and participate in telehealth sessions. Those unable to follow the study's safety requirements can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive 4 telehealth sessions over 1 hour each over 4 months. Patients also receive an intervention guidebook.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Diet Support Intervention
- Telemedicine Visit
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator